期刊
VACCINE
卷 25, 期 8, 页码 1464-1469出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2006.10.033
关键词
adjuvant; cdiGMP; immune modulator; vaccine
The identification of new adjuvants is a critical need in vaccinology. In this work, it is demonstrated that bis-(3',5')-cyclic dimeric guanosine monophosphate (cdiGMP) exhibits potent adjuvant properties. Subcutaneous co-administration of cdiGMP with P-galactosidase (P-Gal) to mice resulted in the elicitation of significantly higher antigen-specific serum IgG titres than in animals receiving P-Gal alone. Strong cellular immune responses, which were characterized by a balanced Th1/Th2 pattern, were also observed in response to the P-Gal protein and a peptide encompassing its MHC class I-restricted epitope in immunized animals. These results suggest that cdiGMP represents a promising adjuvant for vaccine development. (c) 2006 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据